| 卵巢癌患者血清CEA CA125 HE4 CA724联合检测的临床价值 |
| |
| 引用本文： | 于海涛,刘秀娜.卵巢癌患者血清CEA CA125 HE4 CA724联合检测的临床价值[J].临床医药实践,2015(2):100-102. |
| |
| 作者姓名： | 于海涛 刘秀娜 |
| |
| 作者单位： | 威海市文登中心医院,山东 威海,264400 |
| |
| 摘 要： | 目的:探讨血清CEA,CA125,HE4,CA724联合检测对早期卵巢癌患者诊断的临床价值。方法:选取45例健康体检者、45例卵巢癌患者和45例卵巢良性病变患者,采用酶联免疫法对所有患者血清CEA,CA125,HE4和CA724进行检测。结果:CEA,CA125,HE4和CA724水平卵巢癌患者血清明显比健康患者和卵巢良性病变患者水平高,组间比较差异有统计学意义,P<0.05;健康体检者血清与卵巢良性病变患者比较,差异无统计学意义,P>0.05。结论:血清CEA,CA125,HE4和CA724联合检测对早期卵巢癌患者诊断具有重要意义。
|
| 关 键 词： | 联合检测 卵巢癌 酶联免疫法 |
The clinical value of detecting the serum levels of CEA,CA125,HE4 and CA724 in patients with o-varian carcinoma |
| |
| YU Hai-tao,LIU Xiu-na.The clinical value of detecting the serum levels of CEA,CA125,HE4 and CA724 in patients with o-varian carcinoma[J].Proceeding of Clinical Medicine,2015(2):100-102. |
| |
| Authors: | YU Hai-tao LIU Xiu-na |
| |
| Institution: | YU Hai-tao;LIU Xiu-na;Weihai Central Hospital of Wendeng; |
| |
| Abstract: | |
| |
| Keywords: | joint detection ovarian cancer enzyMe linked iMMunosorbent assay |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
